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Anxiety disorders are among the most prevalent psychiatric disorders among both adults and 
adolescents. Comorbidity with other psychiatric disorders, including other anxiety disorders, 
is common and it is clear that a high degree of burden of distress and impairment is 
associated with the condition. Substantial evidence has been presented to suggest a strong 
genetic component in the aetiology of anxiety disorders. Twin and family studies suggest that 
panic disorder, general anxiety disorder, phobias and obsessive-compulsive disorder (OCD) 
aggregate in families. Twin studies in particular shown greater intrapair resemblance between 
monozygotic twins compared to dizygotic twins, suggesting a strong genetic component. 
Several genes have been implicated in the genetic aetiology of anxiety disorders, the most 
prominent of which are BDNF and SCL6A4. Furthermore, the role of the HPA axis in the 
regulation of the normal response to fear and stress may be influenced by genes contributing 
to cortisol functions such as FKBP5 and CRHR1. The severity of childhood trauma can 
contribute to the development of anxiety disorders by modulating gene expression. In this 
study anxiety sensitivity (AS) is investigated as a possible predictive marker for development 
of anxiety disorders. Adolescents (13-18 years of age) were recruited from senior secondary 
schools in the Cape Town area of the Western Cape. Participants were subjected to 
psychological screening, which included the childhood anxiety sensitivity index (CASI) as 
well as the childhood trauma questionnaire (CTQ), and saliva samples were collected and 
genotyping conducted.  Gene-environment (G × E) interactions, focussing on the severity of 
childhood trauma and selected genetic variants, were investigated to determine how levels of 
AS in a South African adolescent population were modulated. Our cohort consisted of 
predominantly Xhosa and Coloured individuals and analysis was done on both ethnic groups 
separately. Significant findings in FKBP5 and CRHR1 in males of both ethnic groups 
suggests sex linked effect in genes regulating cortisol function. The severity of childhood 
trauma was found to modulate selected variants which is in line with previous literature.  AS 
may be seen as a precursor to the development of anxiety- and anxiety-related disorders, and 
a potential clinical marker for early diagnoses of anxiety disorders. 
 
 




Angsversteurings is een van die mees algemene psigiatriese versteurings onder beide 
volwassenes en tieners. Medemorbiditeit met ander psigiatriese versteurings asook 
medemorbiditeit onder angsversteurings is algemeen. Verder is dit duidelik dat 'n hoë graad 
van las van nood en gebrek verband hou met die lyding van angsversteurings. ‘n Aansienlike 
hoeveelheid bewyse is beskikbaar in die literatuur dat daar 'n sterk genetiese komponent as 
deel van die etiologie van angsversteurings bestaan. Tweeling en familie studies dui daarop 
dat paniekversteuring, algemene angsversteuring, fobies en obsessiewe kompulsiewe 
versteuring in families meer algemeen vertoon. Tweeling studies veral wys groter intra-paar 
ooreenkoms tussen monosigotiese tweelinge in vergelyking met disigotiese tweelinge, wat 
dui dat die ooreenkoms geneties is eerder as die omgewing waarin die tweelinge hul self 
bevind. Verskeie gene word geïmpliseer by die genetiese etiologie van angsversteurings 
waarvan die mees prominente gene BDNF en SCL6A4 is. Verder,  die rol van die HPA-as in 
die regulering van die normale reaksie op vrees en stres, kan beïnvloed word deur gene wat 
bydra tot kortisol funksie beheer soos FKBP5 en CRHR1. Kinderjare trauma kan ook bydra 
tot die ontwikkeling van angsversteurings, asook 'n modulerende uitwerking hê op gene. In 
hierdie studie word angs sensitiwiteit (AS) ondersoek as 'n moontlike voorspellende merker 
vir die ontwikkeling van angsversteurings. Adolessente (13-18 jaar oud) is gewerf uit senior 
sekondêre skole in die Kaapstad-omgewing van die Wes-Kaap om aan die studie deel te 
neem. Deelnemers is blootgestel aan sielkundige vraelyste soos die kinderjare angs 
sensitiwiteit indeks (CASI) asook die kinderjare trauma vraelys (CTQ), en speeksel monsters 
is ingesamel en genotipering is gedoen. Geen-omgewing (G × E) interaksies, met die fokus 
op die erns van kinderjare trauma en gekose genetiese variante is ondersoek, om ten einde vas 
te stel hoe vlakke van AS in 'n Suid-Afrikaanse adolessente bevolking is gemoduleer word. 
Ons studie groep bestaan uit oorwegend Xhosa en Bruin deelnemers en ontleding is gedoen 
op beide etniese groepe afsonderlik. Beduidende bevindinge in FKBP5 en CRHR1 by mans 
van beide etniese groepe dui op 'n geslagsgekoppelde effek in gene wat kortisol funksie 
reguleer. Kinderjare trauma is ook gevind om sekere variante te beïnvloed wat in lyn is met 
die vorige literatuur bevindings. AS kan gesien word as 'n voorloper tot die ontwikkeling van 
angs- en-angs verwante versteurings, en dus as 'n potensiële kliniese merker gebruik kan 
word tot die vroeë diagnoseering van angs versteurings. 
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I. Introduction  
I.1 Anxiety disorders 
Anxiety disorders are among the most prevalent psychiatric disorders globally (Kessler et al., 
2010; Lester and Eley, 2013; Wittchen et al., 2011a). Indeed, one quarter of the European 
population is classified as having one or more anxiety disorder (Wittchen et al., 2011), and it 
has been estimated that a quarter of the population in Western countries meets the criteria for 
an anxiety or mood disorder in a given year. In South Africa, the lifetime prevalence of 
mental disorders is estimated at around 30%, with the most prevalent of these disorders being 
anxiety disorders, estimated at around 15% (Herman et al., 2009). From the projected lifetime 
risk estimates, it is estimated that almost half (47.5%) of the South African population will 
develop a mental disorder in their lifetime (Kessler et al., 2007). Despite the prevalence of 
these disorders, as well as the cost and high burden of disease, only about a quarter of 
individuals suffering from anxiety disorders in South Africa receive any form of treatment 
(Seedat et al., 2008). This seems to mirror data from Europe regarding depression and its 
treatment, as well as data from the United States of America. According to the Depression 
Research In European Society (DEPRES) survey only 25% of patients with major depressive 
disorder receive antidepressant medication (Tylee et al., 1999), whilst the Ontario Health 
Survey reported underuse of services for patients with mental disorders in both the US and 
Canada. Women have a higher prevalence of mental disorders and approximately a 10% 
higher incidence than men (Wittchen et al., 2011b; Wittchen and Jacobi, 2005).  Men have 
been reported to show higher levels of free cortisol in response to acute stress, however some 
studies have shown equal responses in cortisol with females experiencing more negative 
effects (Foley and Kirschbaum, 2010). Women report higher levels of fear, irritability, 
confusion and less happiness after completion of the Trier Social Stress Test (Kelly et al., 
2008).  
Anxiety disorders are also the most prevalent psychiatric disorders reported in adolescents 
and have been shown to be linked with maladaptive outcomes in later life (Legrand et al., 
1999a). Many anxiety disorders can develop in childhood and may persist into adulthood if 
not treated.  A recent meta-analysis, using data from 27 countries including South Africa, 
reported a pooled estimate of 13.4% of children and adolescents affected by mental disorders 
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of which anxiety disorders were the most prevalent, affecting 117 million children and 
adolescents (Polanczyk et al., 2015). 
It is clear that these disorders carry a high degree of burden of distress and impairment 
comparable to other chronic somatic disorders (Hettema, Neale et al. 2001). However, the 
exact impact of these disorders at a population level is still very poorly described. Recent 
studies indicate that the burden of disease is higher than previously estimated and that mental 
health may be one of the biggest global health challenges of our time (Wittchen et al., 
2011b). A paper written by Olesen et al. (2010) estimated that the cost of mental disorders in 
Europe was €798 billion, of which anxiety disorders cost € 74.4 billion.   
Research into the aetiology of anxiety disorders indicates that they are multifactorial in 
origin, and are highly comorbid with each other (Chavira et al., 2009; Davis L et al., 2010; 
Gureje, 2008; King-Kallimanis B et al., 2009). Some researchers have already pointed out the 
fallacy of extrapolating clinical data obtained in developed countries to the South African 
population (Wright et al., 2011).  The ethnic and cultural diversity that our country is known 
for presents specific challenges for predicting disease progression and how patients with 
anxiety disorders respond to treatment. These outcomes cannot be determined by clinical 
characteristics alone. Studying the aetiology of the disorder has been suggested to be the most 
favoured approach (Lester and Eley, 2013), as genetic and environmental factors contribute 
to differences in course and treatment response across patient demographics (Lester and Eley, 
2013).  
Data from family and twin studies implicate genetics as a contributor to the aetiology of 
anxiety disorders (reviewed in Smoller, 2016; Plomin et al., 2016). Indeed, several studies 
have reported that anxiety disorders tend to aggregate in families (Lau and Eley, 2010; 
Legrand et al., 1999b).  This phenomenon may be accounted for by a genetic predisposition 
to anxiety disorders; however, the impact of environmental factors that could mediate the 
susceptibility to anxiety disorders cannot be discounted.  Twin studies are often the model of 
choice used in cases where genetic and environmental influences may be skewed, and these 
studies facilitate the delineation of genetic and familial contributory factors.  Studies such as 
these intend to give a heritability estimate of the particular disorder, which translates into the 
likelihood of developing a certain disorder based on the genetic propensity of an individual 
(Legrand et al., 1999a). Although there is a complex interplay between environmental factors 
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and genetics, in some anxiety disorders the estimated genetic contribution can approach 40% 
(Domschke and Deckert, 2012; Erhardt and Spoormaker, 2013). The heritability of anxiety 
disorders, however, is not Mendelian in nature (Craddock and Sklar, 2013). Alleles that are 
thought to be linked to susceptibility (for any disorder) may have a range of effect sizes, as 
well as different frequencies within populations, ranging from rare to common (Craddock and 
Sklar, 2013; Wang et al., 2005). In the South African context, these factors make undertaking 
genetic studies more difficult as the population is very diverse, with different population 
groups that do not necessarily share a common genetic ancestry.  
Below is a summary table of the known anxiety disorders and a brief description of their 
clinical presentation according to the DSM-5 diagnostic criteria (American Psychiatric 
Association, 2013). 
Table 1.1 DSM-5 classifications of anxiety disorders 
Separation anxiety disorder Inappropriate and excessive fear or anxiety 
related to separation from people to whom 
the individual feels attached. The anxiety 
exceeds what is normally expected for the 
given age of the individual 
Selective Mutism Children who do not initiate speech nor 
reciprocate any verbal communication when 
encountering other individuals during social 
interactions. Normally those with selective 
mutism speak only in their home with 
immediate family members 
Specific Phobia Excessive fear or anxiety in the presence of a 
particular situation or object. The fear or 
anxiety is also experienced nearly every time 
the stimulus is present 
Social anxiety disorder (social phobia) Fear or anxiety of social interactions in 
which the individual feels he/she may be 
evaluated by others 
Stellenbosch University  https://scholar.sun.ac.za
15 
 
Panic Disorder Individuals suffer recurring and unexpected 
panic attacks 
Agoraphobia Intense fear or anxiety experienced about two 
or more of the following situations: using 
public transportation, being in open spaces, 
being in enclosed spaces, standing in line or 
being in a crown, and being outside of the 
home alone 
Generalized anxiety disorder Excessive anxiety and apprehension about a 
number of situations or activities, which the 
duration and intensity of the anxiety 
disproportionate to the likelihood of 
experiencing the negative event or the impact 
that the event may have 
Substance/Medication-induced anxiety 
disorder 
Symptoms of panic and/or anxiety that are 
due to the effects of a substance such as drug 
abuse, medication, or toxin exposure. The 
symptoms develop during or soon after 
exposure to the substance or withdrawal 
from use 
 
I.2 The HPA axis: its role in anxiety 
Fear is a natural emotional response to an immediate perceived threat, whilst anxiety is 
experienced in anticipation of future threats (Shin and Liberzon, 2010). Both fear and anxiety 
are necessary for physiological preparation to threatening situations such as the fight-or-flight 
response or increasing muscle tension and vigilance in anticipation of a threat.  Fear is a 
biologically adaptive physiological and behavioural response to stimuli and may represent an 
actual or an anticipated threat to the individual’s well-being.  Under conditions of normal 
brain function, stimuli that may represent danger or potential danger elicit a response to these 
threats, but also receive preferential processing by the brain (Williams et al., 2010).  Anxiety 
is triggered by generalised and less explicit signals and involves more uncertainty as to the 
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expectancy of threat (Bishop 2007). It has been shown in literature that anxious individuals 
are more likely to interpret emotionally ambiguous cues as threatening, and will display 
attentional bias to signals of danger (Li et al., 2005). 
 
The normal response to stress can be viewed as two different time responses, a quick 
response mediated by the autonomic nervous system (ANS), and a delayed response 
mediated by the hypothalamic–pituitary–adrenal (HPA) axis (Lucassen et al., 2013). The first 
response is the “fight-or-flight” response which readies the body for immediate action by 
ANS stimulation of release of epinephrine and norepinephrine. Epinephrine and 
norepinephrine work to increase the basal metabolic rate, increase blood pressure and 
respiration, and increase blood flow to the heart and skeletal muscles all in preparation for 
response to threatening stimuli (Lucassen et al., 2013). The hypothalamic–pituitary–adrenal 
(HPA) axis plays a critical role in the regulation of the long-term response to fear and stress 
(Lucassen et al., 2013; McVicar et al., 2014; Schatzberg et al., 2014), and as such, plays a 
role in pathogenesis of anxiety disorders. Figure 1 is a graphical representation of the HPA 
axis showing the negative feedback regulation of the axis, from adrenocorticotrophic 
hormone-releasing factor (CRF) and vasopressin (AVP) release from the hypothalamus onto 
adrenocorticotrophic hormone (ACTH) secretion from the pituitary which stimulates the 
release of glucocorticoids (cortisol) from the adrenal cortex. Cortisol again regulates the 
secretion of CRF and AVP in a dose dependent manner. Cortisol binds to mineralocorticoid 
(MR) and glucocorticoid (GR) receptors in the hippocampus which inhibits the secretion of 
corticotropin-releasing hormone (CRH). Furthermore, cortisol may also bind to GR in the 
anterior pituitary and inhibit the secretion of ACTH and consequently inhibit its own 
secretion through a negative feedback mechanism (Lucassen et al., 2013; McVicar et al., 
2014; Shin and Liberzon, 2010).   




Figure 1. Schematic representation of the hypothalamic-pituitary-adrenal (HPA) axis adapted from (Pariante 
CM and Lightman SL, 2008). Cortisol release from the adrenal cortex is mediated through the secretion of many 
precursor hormones and is inhibited by its binding to receptors upstream of it secretion via negative feedback. It 
is hypothesized that early life trauma can affect the normal function of the HPA axis thereby contributing to the 
development of anxiety disorders. Abbreviations: Adrenocorticotrophic hormone-releasing factor (CRF), 
arginine vasopressin (AVP), adrenocorticotrophic hormone (ACTH), glucocorticoid receptors (GR). 
Anxiety disorders are characterised by a persistent stimulation of the HPA axis, which can 
result in HPA axis dysregulation. In rodent models, adult rodents who were exposed to high 
levels of corticosteroids in infancy experienced hyperactivity of the HPA axis and showed 
altered affective behaviour similar to anxiety (Seckl JR and Holmes MC, 2007). Hyper-
activation of the HPA axis can be caused by impaired signalling of GR which negates the 
negative feedback mechanism, leading to over expression of CRH, AVP and ACTH and 
eventually resulting in to increased basal cortisol levels (Ising et al., 2008). Cortisol levels in 
humans with PTSD have been reported to be lower than the expected norm, suggesting 
increased tissue sensitivity to glucocorticoids and subsequently enhance feedback 
mechanisms (Yehuda et al., 2004). Two genes that are described later, FK506 binding protein 
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5 (FKBP5) and Corticotropin-releasing hormone receptor 1  (CRHR1), have been linked to 
cortisol dysregulation and depression, anxiety and PTSD (Mahon et al., 2013a). 
I.3 Childhood trauma 
Childhood trauma is any action or event that causes significant harm to a child’s body or 
psyche (DSM 5, American Psychiatric Association, 2013).  This can include verbal, physical, 
emotional or sexual abuse, witnessing a violent act or crime, the death of a friend or relative, 
and any other experience that may cause trauma (DSM 5, American Psychiatric Association, 
2013). Childhood trauma is a risk factor for several mental disorders and has been found to 
have a modulating effect on a number of genes, including sodium-dependent serotonin 
transporter and solute carrier family 6 member 4  (SLC6A4),  brain derived neurotropic factor 
(BDNF), FKBP5,  and CRHR1 genes (Carola and Gross, 2010a; Elzinga et al., 2011; Klauke 
et al., 2014, 2011a; Klengel et al., 2013a; Lardinois et al., 2011; Xie et al., 2010).  
Childhood trauma can be assessed using the Childhood Trauma Questionnaire 
(CTQ)(Bernstein et al., 1994), which is one of the most widely used measures in the trauma 
field. The CTQ is a 28 item self-report inventory measuring the severity of the following 
subscales: emotional abuse, physical abuse, sexual abuse, emotional neglect, and physical 
neglect. The total score provides an indication of the severity of trauma.  The CTQ also 
assesses tendency to under report maltreatment (Bernstein et al., 1994; Villano et al., 2004).  
Trauma, as an environmental factor, is thought to influence genes by modification of their 
expression, which in turn increases the risk for development of psychiatric disorders (Klauke 
et al., 2011a; Lardinois et al., 2011).  Genes, such as BDNF, SLC6A4, neuropeptide Y 
receptor 1 (NPYR1) and Catechol-O-methyltransferase (COMT), have all been shown to be 
influenced by childhood trauma (Baumann et al., 2013; Carola and Gross, 2010b; Klauke et 
al., 2011b; Wu et al., 2011). As childhood trauma has been consistently linked to the later 
development of psychiatric disorders, it is important to evaluate childhood trauma exposure 
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Table 1.2 Summary of studies looking at genetic variants and early life events with regards to anxiety disorders 
(Adapted from Nugent et al., 2011). 
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I.4 Importance of adolescent studies 
Adolescence is an important developmental period where the brain is still developing and 
changes relating to puberty and  the environment can influence susceptibility  to  the 
development of psychiatric disorders such as anxiety and depression (Comasco et al., 2015; 
ROMEO and M cEWEN, 2006). The mechanism behind this increased vulnerability is still 
unclear although exposure to stressful stimuli is thought to contribute significantly (Eiland L 
and Romeo RD, 2013; Turner and Lloyd, 2004). In-vivo investigation of stress and anxiety in 
adolescents has largely been restricted to animal models, since it is difficult to do stress 
related testing in  young humans, as the effects of stressors at young ages are not fully known 
(Doremus-Fitzwater et al., 2009; Spear, 2000). Structural and functional changes have been 
observed in the limbic and cortical regions of the developing adolescent brain (Giedd et al., 
1999; Gogtay N et al., 2004). Furthermore, changes in the reactivity of the HPA axis in 
response to stressors have been observed in models using adolescent rodents (Cruz et al., 
2008; Romeo et al., 2006). These studies have also found a variation in  corticosterone 
(cortisol in humans) between male and female rodents (Doremus-Fitzwater et al., 2009). It is 
clear that there are major differences between adolescent and adult brains, however these 
differences are mainly known in rodents. In this regard, it is imperative for the identification 
and early intervention of anxiety in youth that human studies be undertaken (Eiland L and 
Romeo RD, 2013; Giedd JN, 2008; Wiggins et al.,2014) 
I.5 Endophenotypes of anxiety disorders 
Endophenotypes are described as biologically informed, quantifiable intermediate phenotypes 
that are more closely related to the genotype than the more complex phenotypes of the 
disorder (Gottesman and Gould, 2003). Endophenotypes must segregate with the illness in 
the general population, they must be heritable, they must manifest whether the illness is 
present or not, they should co-segregate within families, and should present at a higher rate in 
families with the illness. Finally an endophenotype should be measured reliably and be 
specific to the illness in question (Beauchaine, 2009; Gottesman and Gould, 2003).  
Psychiatric disorders are highly comorbid and comorbid disorders may be difficult to tease 
apart. This is especially true for anxiety disorders (Gureje, 2008; King-Kallimanis B et al., 
2009) It thus follows that the search for genetically informed endophenotypes can be 
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immensely useful in unmasking the aetiology of complex disorders, such as anxiety 
disorders.  A substantial body of literature exists to describe the relationship of certain 
anxiety-related traits, such as anxiety sensitivity (AS) and trait anxiety (TA) (Grant et al., 
2007; McNally, 1989; Naragon-Gainey, 2010a; Olatunji and Wolitzky-Taylor, 2009; Plehn 
and Peterson, 2002; Schmidt et al., 1997; Taylor, 1995; Zavos et al., 2012c) with 
psychopathology. This is especially true for anxiety sensitivity. No study to our knowledge 
has confirmed AS or TA as endophenotypes, however they may be considered candidates 
based on the criterion described by Gottesman and Gould (2003). These traits are heritable 
(Legrand et al., 1999b), they are measurable in groups without anxiety disorders (Lambert et 
al., 2004), they are found in family members (Drake and Kearney, 2008), and they can be 
measured reliably (McNally, 1989). 
I.6 Anxiety Sensitivity  
Individuals classified as anxious live in a state in which they perpetually focus on a future 
likelihood of experiencing some aversive emotional or physical sensation (Paulus and Stein, 
2006).  Within cognitive-behavioural models, anxiety sensitivity (AS) is described as the 
tendency of individuals to view the experience of anxiety or other negative emotional states 
with fear (Paulus and Stein, 2006)(Naragon-Gainey, 2010b).  Anxiety sensitivity is often 
referred to as an anxiety amplifier – anxious symptoms induce the fear within the individual 
(they become anxious due to their anxious feelings). Individuals with high AS are thought to 
perceive arousal of the autonomic system, such as increased heart rate, as an indicator of 
impending harm, and as a result, experience anxiety (they may also potentially experience 
panic attacks) (Schmidt et al., 2010, 2006a) 
High AS has been linked to an increased likelihood of developing an anxiety disorder, such 
as panic disorder (Plehn and Peterson, 2002).  Panic attacks are thought of as causing a 
conditioning of anxiety which leads to the individual fearing a recurrence of the panic attack 
and therefore increasing levels of AS, but also inversely relating to the fact that high levels of 
AS increases the likelihood of reoccurrence of a panic attack (Paulus and Stein, 2006).  AS is 
not, however, limited to increased susceptibility to panic disorders; many disorders, such as 
anxiety, depression, phobias, hypochondriasis and substance abuse have all been found to 
have elevated levels of AS (Naragon-Gainey, 2010b)(Olatunji and Wolitzky-Taylor, 2009). 
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The Anxiety Sensitivy Index (ASI) is a widely used tool to measure AS (Peterson and 
Heilbronner, 1987). The original and standard ASI is a 16-item index that measures the 
concern a person has about potentially negative outcomes of having anxiety symptoms 
(Olatunji and Wolitzky-Taylor, 2009).  AS is characterised by a hierarchical structure, with 
three lower-order factors, physical symptoms (fear of experiencing anxiety), publically 
observable anxiety symptoms (fear that others will notice the anxiety) and cognitive 
dyscontrol (fear of losing one’s mind), loading on the higher order construct of AS : (Olatunji 
and Wolitzky-Taylor, 2009)(Naragon-Gainey, 2010b). Anxiety sensitivity in children and 
adolescents is assessed using the Childhood Anxiety Sensitivity Index (CASI) which is a 
formatted version of the ASI that is set up in a more child friendly manner (Silverman et al., 
1991). Since its conception in 1991, the CASI has been shown to have incremental validity 
and has been confirmed to be as effective as the ASI, validating its use in children and 
adolescents (Essau et al., 2010; Lambert et al., 2004; Schmidt et al., 2010). 
 
I.7 Genetics of AS  
Strong evidence from twin studies indicate that familial aggregation occurs with regards to 
anxiety disorders; however, results have been inconsistent in many cases. The source of this 
familial aggregation can be strongly suggested to be genetic in origin, specifically indicated 
by twin studies, in which greater intra-pair resemblance between monozygotic versus 
dizygotic twins is due to genetic similarity rather than environmental similarity (Hettema, 
Neale et al. 2001).  Family studies have shown a three- to five-fold increase in the risk for 
development of anxiety disorders if a first-degree relative suffers from panic disorder, 
generalized anxiety disorder or specific phobias (Domschke, 2013). One of the obvious draw 
backs to these types of twin studies are the size of samples included in studies (Hettema et al., 
2005). Anxiety Sensitivity has been shown to be a risk factor for a number of affective 
disorders such as panic disorder, generalized anxiety disorder and depression (Stein et al., 
2007a). AS has also been put forward as a potential intermediate phenotype for anxiety 
disorders (Schmidt et al., 2006b). Twin studies have reported heritability for these disorders 
(Eley et al., 2007) and there is evidence that AS is a core component of this phenotype 
(Naragon-Gainey, 2010b; Olatunji and Wolitzky-Taylor, 2009; Stein et al., 2007a; Zavos et 
al., 2012c). Heritability of AS is estimated to be around 50% in adults (Stein et al., 1999), 
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37% in childhood (Eley et al., 2007), and 47% in adolescence (Zavos et al., 2010). AS has 
been found to be phenotypically stable, meaning that AS measured in adolescence is often 
similar to AS measured in adulthood (Zavos et al., 2012a). Levels of childhood maltreatment 
have been shown to influence AS in the context of certain genetic variants such as 5HTTLPR 
(Stein et al., 2007b).  
 
I.8 Genetic aetiology of anxiety disorders 
The serotonin transporter gene (SLC6A4) and BDNF, are two of the most widely studied with 
regards to the association of specific SNPs (single nucleotide polymorphisms) in these genes 
and anxiety and stress-related disorders (e.g. post-traumatic stress disorder (Martinowich et 
al., 2007a; Montag et al., 2010; Schmidt and Duman, 2010).  The serotonin transporter, also 
known as SLC6A4, has been well documented in terms of its function in regulating serotonin 
levels in the brain. The SLC6A4 gene has polymorphisms in its promoter region that affects 
the transcription of the serotonin transporter and its subunits (Klauke et al., 2011b; Nordquist 
and Oreland, 2010; Smits et al., 2008; Uher and McGuffin, 2007).  The 5-hydroxytryptamine 
transporter-linked polymorphic region (5HTTLPR) gene has been implicated in the aetiology 
of many psychiatric disorders, such as depression, anxiety, schizophrenia, substance abuse 
disorders, autism spectrum disorders, and others (Nordquist and Oreland, 2010)(Plieger et al., 
2014). A great body of evidence speaks to serotonin’s function in determining behavioural 
traits as well as its role in the aetiology of several psychiatric disorders  (Guiard et al., 2008; 
Klauke et al., 2011b; Miller et al., 2009; Nordquist and Oreland, 2010; Stein et al., 2007a; 
Uher and McGuffin, 2007; Zavos et al., 2012c). While there is a growing body of evidence 
pointing toward a functional correlation to the 5HTTLPR genotypes (Zavos et al., 2012c), 
some studies have also shown no link between the serotonin transporter gene and anxiety 
disorders (Chorbov et al., 2007; Jorm et al., 1998a; Laucht et al., 2009b; Power et al., 2010a). 
Findings have been inconsistent, in part because of the complex nature of polymorphisms and 
alleles within this gene. The 5HTTLPR is a variable number tandem repeat (VNTR) marker 
of which there are two  alleles of interest to this study , a short “S” allele, which has been 
associated with decreased serotonin transporter expression (Uher, 2008) and therefore 
decreased so called “positive” outcomes (Caspi et al., 2003; Karg et al., 2011; Uher and 
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McGuffin, 2007). The long “L” allele has been shown to be linked to increased serotonin 
transporter expression and “anxiety-like traits”.  
Brain derived neurotrophic factor (BDNF) is a protein involved in the regulation of neural 
growth and stimulation of synaptic plasticity. BDNF belongs to a family of neurotrophic 
factors that influence proliferation, migration, differentiation, growth and apoptosis of 
mammalian neural cells (Hashimoto K, 2007). Recently BDNF has become a focal point for 
research into depression and anxiety (Montag et al., 2010). Data suggests that BDNF could 
play a modulatory role in the experience-dependent programming of anxiety. Certain 
polymorphisms in BDNF, such as the Val66Met variant, have been found to mediate altered 
anxiety-like behaviour in rat models; however not all results are consistent (Domschke et al., 
2010; Elzinga et al., 2011; Martinowich et al., 2007a; Montag et al., 2010, 2008; Schmidt and 
Duman, 2010). Rats with the non-synonymous Val66Met polymorphism have been found to 
be more sensitive towards early life events, with stressors at early development leading to 
greater risks of anxiety and depression in later life stages (Carola and Gross, 2010b). These 
discrepancies may point to a greater environmental influence on BDNF function and its role 
in anxiety.  
Exposure to stressors has been shown to alter expression of BDNF in the hippocampus 
(Schmidt and Duman, 2010), whilst chronic use of antidepressants increases expression of 
BDNF in these brain regions. BDNF expression and signalling seems to play an important 
role in the normal response to antidepressants as a variety of BDNF deficient mice show little 
or no behavioural response to antidepressant administration (Schmidt and Duman, 2010).  
However, BDNF mutant mice only show increases in their stressed behaviour when exposed 
to stressful environments. Under ‘no stress’ conditions the knockout of BDNF function seems 
to have no effect on behaviour. This suggests that BDNF does not cause depressive or 
anxious behaviour with its absence, but rather the lack of proper BDNF expression leads to  
decreased coping mechanisms in response to stressful life events (Domschke et al., 2010; 
Schmidt and Duman, 2010).  
BDNF is a potential biomarker for MDD and/or antidepressant treatment efficacy, which 
could also potentially mean that the genetic variations in the BDNF gene could serve as 
markers of other affective disorders (Schmidt and Duman, 2010). BDNF expression levels 
have been found to correlate with increased depression and anxiety in several studies. More 
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importantly, several studies have shown increased levels of BDNF post mortem in depressed 
patients who were treated with antidepressants (Martinowich et al., 2007a; Montag et al., 
2010). Findings such as these have led to the hypothesis that BDNF may play some role in 
the recovery process from depression. In contrast to this however, several animal studies have 
found that infusion of BDNF to areas of the brain can lead to depressive-like behaviour 
(Montag et al., 2010). Conflicts in findings such as these, point toward specific functioning of 
BDNF within specific regions of the brain.  
The critical role that BDNF plays to maintain and promote normal neuronal growth and 
function makes it a key point of investigation for the aetiological study of disorders of the 
mind.  Not only is it clear that abnormal functioning of BDNF leads to deficiencies in neural 
upkeep, which in turn may lead to psychopathology, but also that BDNF is susceptible to 
epigenetic modifications (Elzinga et al., 2011; Martinowich et al., 2007a; Middeldorp et al., 
2010).  Disagreement across various studies about the specific role of BDNF also lends 
credence to the possibility that the whole picture of BDNF and its role in the development of 
anxiety disorders may be moderated by a combination of genetic and epigenetic mechanisms 
(Domschke et al., 2010; Elzinga et al., 2011). 
Corticotrophin-releasing hormone (CRH) and CRH type 1 receptor gene (CRHR1) are 
important mediators of the stress response (Wang et al., 2012).  Subsequently CRHR1 has 
been thought to play a role in the pathophysiology of anxiety disorders, this is based in part 
on studies done on transgenic mice (Heinrichs and Koob, 2004; Reul and Holsboer, 2002).  
Hormonal control of stress through the HPA (Hypothalamic-pituitary-adrenal) axis is 
important in the long term response to stress, as well as influence autonomic response to 
stress under chronic conditions. A CRHR1 antagonist may act as an anxiolytic as mice that 
over express CRH show increased anxiety like behaviour, whilst mice that are CRHR1 
knockout show reduced levels of anxiety (Reul and Holsboer, 2002; Timpl et al., 1998; Wang 
et al., 2012).  Early life trauma or stress has also been shown to influence the expression of 
CRHR1 and specifically increases the levels of CRH that is present in the hippocampus 
(Fenoglio et al., 2006). This modification of the normal stress response is further exacerbated 
by the presence of early life trauma (Faravelli et al., 2012) adding to the complex nature of 
the pathogenesis of anxiety disorders.  
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Glucocorticoid receptors (GR) are vital for a healthy response to stress. These receptors 
mediate the body’s natural stress response through a negative feedback control. 
Glucocorticoids bind to GR to activate the so called ‘Fight or Flight’ response, readying the 
body for activity and terminating the response when danger has passed. The negative 
feedback loop of GR is integral to normal stress response. Over-activation of this system has 
been linked to several mood disorders. Partial glucocorticoid resistance is observed in mood 
disorders due to improper signalling of GR (Binder, 2009). 
GR is ligand-activated and translocates from the cytosol to the nucleus through a large 
molecular complex. Chaperone molecules, called heatshock proteins (hsp), allow for the 
proper folding of peptides and proteins within this molecular machinery. FK506 binding 
protein 51 (FKBP5) is a co-chaperone playing a role in the proper folding and binding of GR 
and has been associated with the pathophysiology of several disorders (Appel et al., 2011b, p. 
5; Binder, 2009; Binder et al., 2004a, p. 5; Klengel et al., 2013a, p. 5). Polymorphisms in the 
FKBP5 gene have been found to be involved in GR resistance and linked to susceptibility to 
the development of post-traumatic stress disorder (Xie et al., 2010). Genetic variation within 
the FKBP5 gene could alter the sensitivity of the stress response pathway, especially during 
development, possibly putting individuals at risk for development of psychiatric disorders 
(Xie et al., 2010). FKBP5 has been studied in the context of childhood adversity/trauma and 
its role in mediating susceptibility to disorders such as depression, PTSD and anxiety (Appel 
et al., 2011; Binder, 2009; Binder et al., 2004; Klengel et al., 2013; Xie et al., 2010).  
I.1.9 The present study 
Clinical and demographic indicators have proven to be ineffective as predictors of treatment 
outcomes (Lester and Eley, 2013), which has sparked an interest in finding biomarkers that 
may more accurately predict treatment responses (Lester and Eley, 2013; Bieber, 2013; 
Trusheim et al., 2011, 2007)). It is within this context that endophenotypes may be useful to 
improve diagnosis as well as potentially play a role in treatment response prediction as well. 
Early detection of mental disorders is preferable in order to improve clinical treatment as well 
as treatment outcomes. AS stands out in the literature as a robust predictive endophenotype 
for anxiety disorders. AS is a well-studied risk factor for anxiety disorders (Stein et al., 
2007b) and has been investigated as an intermediate phenotype for anxiety disorders 
(Schmidt et al., 2006b). For these reasons and others as described above, AS was used in this 
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study as a risk marker for anxiety in adolescents. FKBP5, BDNF, CRHR1, and SLC6A4 are 
genes that have been previously implicated in the aetiopathogenesis of anxiety disorders and 
have been associated with AS as well as with adverse life events (Comasco et al., 2015, p. 5; 
Mahon et al., 2013a; Martinowich et al., 2007b; Zavos et al., 2012c). Accordingly, these 
genes have been selected for investigation in our study. 
Study objectives 
This study aims to investigate anxiety sensitivity (AS) (measured as CASI total score) as a 
predictive marker of susceptibility risk for anxiety disorders in an adolescent South African 
cohort, considering previously identified genetic risk variants. Furthermore, the addition of 
environmental exposure, more specifically childhood trauma (measured by CTQ total score), 
will be utilized to investigate gene-environment interactions in the aetiology of AS.  
The study objectives are as follows: 
1. Use regression analysis to determine association between AS and selected genetic 
variants assuming additive allelic, dominant, and recessive models of inheritance. 
2. Use regression analysis to determine whether selected genetic risk variants interact 
with childhood trauma to mediate the development of AS. 
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II. Materials and methods 
II.1 Ethics 
This study falls under the ethics purview of the parent study: Relationship between childhood 
trauma, neuropsychological deficits, neural circuitry, and anxiety proneness in high-anxiety 
and low-anxiety prone adolescents.  The study has been approved by Health Research Ethics 
Committee (HREC) of the Faculty of Medicine and Health Sciences, University of 
Stellenbosch (N10/11/370).  
II.2 Participants 
A total of 1149 study participants (13 – 18 years) were recruited from senior secondary 
schools in the Cape Town area of the Western Cape.   Learners provided written and 
informed assent and written and informed consent was obtained from parents or guardians.  
The inclusion criteria for participation were as follows: (1) the ability to read, write and 
understand English or Afrikaans at the 5th grade level (2) psychotropic drug-naïve (3); 
medically sound and able to undergo psychological testing and magnetic resonance imaging 
(MRI) scanning. Exclusion criteria comprised: (1) prior treatment for anxiety disorders (2) 
current or past history of mental, psychotic or childhood disorders (3) a history of alcohol or 
substance abuse/dependence (4) previous head trauma (5) and currently on psychotropic 
medication. The ethnicities of the participants were Xhosa, Coloured, White, Asian, and 
other; and was determined through self-report (Table 3.1). 
 
II.3 Psychological screening 
All participants were screened by a trained research psychologist to determine self-reported 
levels of childhood maltreatment/trauma, as measured by the childhood trauma questionnaire 
(CTQ)(Bernstein et al., 1994), and anxiety proneness. Anxiety sensitivity, measured by the 
Child Anxiety Sensitivity Index (CASI)(Silverman et al., 1991) and trait anxiety, measured 
by the trait section of the State-Trait Anxiety Inventory (STAI)(Spielberger et al., 1970) were 
selected as predictive markers of anxiety.  Several other screening measures were also 
administered to participants to determine eligibility. 




(1) The Child Anxiety Sensitivity Index (CASI) (Silverman et al., 1991): 
An 18-item self-report questionnaire measuring the fear of anxiety by rating the extent to 
which an experience of anxiety will result in a negative consequence(s).  
(2) The Childhood Trauma Questionnaire (CTQ)(Bernstein et al., 1994): 
A 28-item retrospective measure of the frequency and severity of abuse and neglect 
experienced prior to age 18. The CTQ consists of five subscales that assess emotional, 
physical, and sexual abuse and emotional and physical neglect, respectively. For the purposes 
of the proposed study, enquiry was made into maltreatment experienced prior to age 12. 
 
(3) The Life Events Timeline: 
 Participants were instructed to indicate on a timeline at which age/s major life events 
occurred, as indicated on the CTQ.   
(4) The Center for Epidemiological Studies Depression Scale for children (CES-
DC)(Weissman et al., 1980): 
A 20-item self-report measure of depression symptoms experienced during the past week.  
(5) The Alcohol Use Disorders Identification Test (AUDIT)(Babor et al., 2001; Saunders et 
al., 1993): 
A 10-item self-report measure used to identify hazardous and harmful patterns of alcohol 
consumption during the past year, by assessing recent alcohol use, alcohol dependence 
symptoms and alcohol-related problems. 
(6) The Drug Use Disorders Identification Test (DUDIT)(Berman et al., 2004) :  
A 11-item self-report measure used to identify drug use patterns and various drug-related 
problems. 
(7) The Connor-Davidson Resilience Scale (CD-RISC)(Connor and Davidson, 2003): 
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A 25-item self-report measure that assesses the level of stress coping ability over the past 
month. 
(8) Adolescent Coping Orientation for Problem Experiences (A-COPE)(Patterson and 
McCubbin, 1987): 
A 54-item self-report coping inventory used to measure the behaviour and patterns 
adolescents find helpful in managing problems or difficult situations. 
II.4 Sample collection and DNA extraction 
Of the 1149 participant, 986 saliva samples were collected using Oragene collection tubes 
(DNAGenotek, Canada) and stored at room temperature. DNA was extracted using the 
PrepIT-L2P DNA extraction kit (DNAGenotek, Canada) as per manufacturer’s instruction 
and suspended in 100 µl Tris EDTA (TE) solution for storage at -80 °C.  DNA concentration 
was assessed using the Nanodrop (Delaware, USA). DNA concentration was assessed at an 
absorbance maximum of 260nm (A260) and sample purity assessed using the A260/A280 ratio.  
A ratio of >1.8 was used as a cut-off for inclusion in this study, indicative of low protein 
contamination. DNA samples were stored at -80⁰C.All samples were diluted to a 
concentration of 80 ng/µl using TE buffer.  Samples with concentrations below 80 ng/µl were 
not diluted, but concentrations were noted.  
 
II.5. Polymorphism selection  
Four candidate genes were prioritised based on recent literature and relevance to anxiety 
disorders.   Polymorphisms within these genes were selected using a TagSNP approach as 
well as a literature search focusing on (1) reported functionality of the SNP and (2) relative 
position in the gene (i.e exon vs. intron vs. regulatory region).  Polymorphisms with minor 
allele frequencies (MAFs) ≥ 0.2 were included in the study to select for common variation 
(MAF according to HapMap (NCBI build 36, dbSNP b126) (www.hapmap.org). MAF 
selection was based on CEU (Utah residents with Northern and Western European ancestry 
from the CEPH collection), MKK (Maasai in Kinyawa, Kenya), and YRI (Yoruban in 
Ibadan, Nigeria). If an allele was present at the minimum MAF in all of the above mentioned 
populations, they were included as there is no reference ancestry information available for the 
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South African population a combination of populations was used. A list of genes, selected 
polymorphisms and reported MAFs can be found in Table 2.1 below.  
Table 2.1. List of selected candidate genes and polymorphisms with accompanied minor allele frequencies and 
chromosome locations. 






FKBP5 rs3800373 SNV GRCh38 6:35574699 0.325 Sequenom 
FKBP5 rs9296158 SNV GRCh38 6:35599305 0.359 Sequenom 
FKBP5 rs737054 SNV GRCh38 6:35607710 0.193 Sequenom 
FKBP5 rs6926133  SNV GRCh38 6:35611598 0.192 Sequenom 
FKBP5 rs1360780 SNV GRCh38 6:35639794 0.373 Sequenom 
FKBP5 rs9394309 SNV GRCh38 6:35654004 0.247 Sequenom 
FKBP5 rs9470080 SNV GRCh38 6:35678658 0.363 Sequenom 
BDNF rs11030099 SNV GRCh38 11:27656036 0.229 Sequenom 
BDNF rs6265 SNV GRCh38 11:27658369 0.201 Sequenom 
BDNF rs2049046 SNV GRCh38 11:27702228 0.43 Sequenom 
SLC6A4 rs3813034 SNV GRCh38 17:30197786 0.483 KASP 
SLC6A4 rs1042173 SNV GRCh38 17:30197993 0.485 Sequenom 
SLC6A4 rs6354 SNV GRCh38 17:30222880 0.204 Sequenom 
SLC6A4 rs25531 SNV GRCh38 17:30237328 0.138 Manual genotyping 
CRHR1 rs7209436 SNV GRCh38 17:45792776 0.443 Sequenom 
CRHR1 rs4792887 SNV GRCh38 17:45799654 0.13 Sequenom 
CRHR1 rs110402 SNV GRCh38 17:45802681 0.439 Sequenom 
CRHR1 rs242924 SNV GRCh38 17:45808001 0.436 Sequenom 
SLC6A4 5HTTLPR DRPR GRCh38 17q11.2 N/A Manual genotyping 
MAF were determined using dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/). All MAFs were verified 
using multiple population groups through the HapMap database (http://hapmap.ncbi.nlm.nih.gov/index.html.en). 
MAF above according to CEU population. Abbreviations: Single nucleoitide variation (SNV), Degenerate 
repeat polymorphic region (DRPR), Sequenom’s iPLEX® Gold assay (sequenom), LGC genomics KASP 
technology (KASP), FK506 binding protein 5 (FKBP5), brain derived neurotropic factor (BNDF), sodium-
dependent serotonin transporter and solute carrier family 6 member 4 (SLC6A4), and corticotropin-releasing 
hormone receptor 1 (CRHR1). 
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II.6. Polymerase Chain Reaction (PCR)  
II.6.1. Primer design  
Primer design for the serotonin transporter gene promoter region (5HTTLPR) was obtained 
from Voyiaziakis et al. (2009) and synthesized by Synthetic DNA Laboratory (Molecular and 
Cell Biology, University of Cape Town). All other primers were designed, synthesized and 
wet bench tested by Genome Quebec (Canada) and LGC Genomics (United Kingdom) 
respectively.  
II.6.2. PCR conditions 
II.6.2.1. Serotonin transporter gene (SLC6A4), rs25531  
5HTTLPR   primers were labelled at the 5’ end as follows:  Fluorescently labelled FAM (6-
fluorescein amidite) forward primer: FAM-5’ ATG CCA GCA CCT AAC CCC TAA TGT 3’ 
and un-labelled reverse 5’ GGA CCG CAA GGT GGG CGG GA 3’.  
PCR conditions for in-house genotyping of 5HTTLPR were performed according to the 
manufacturer’s instructions. KAPA 2G Robust HotStart readymix was used for 5HTTLPR. 
PCR conditions for all subsequent genotyping, outsourced to Genome Quebec and LGC 
Genomics were based on standard protocols for Sequenom and KASP technologies. PCRs 
were performed in 25µl reaction volumes of which 9 µl was PCR grade water, 12 µl Kapa2G 
Robust HotStart ReadyMix, 1.25 µl forward primer, 1.25 µl reverse primer, and 1 µl sample 
DNA. PCR conditions were as follows: initial denaturation at 95°C for 3 minutes, followed 
by denaturation at 95°C for 15 seconds cycling 35 times, primer annealing at 60°C for 15 
seconds for 35 cycles, extension at 72°C for 15 seconds for 35 cycles, final extension at 72°C 










The genotyping methods used were as follows (Table 2.1):  
1. Microsatellite length polymorphism analyses 
2. Restriction fragment length polymorphism (RFLP) analyses 
3. KASP® Genotyping 
4. Sequenom genotyping 
 
Subsequent to 5HTTLPR amplification, PCR success was assessed by electrophoresing 5 ul 
of each amplicon on a 2% (w/v) agarose gel. Once complete, the gel was viewed under 
ultraviolet light.  A successful PCR yielded bands of 280 bp (short, S-allele) and/or 320 bp 
(long, L-allele).  
The remaining product was genotyped for rs25531 using a two-stage protocol. The first stage 
involved allele-specific restriction enzyme analysis (ASREA), making use of the MspI 
restriction enzyme as per the manufacturer’s protocol.  Restriction enzyme (RE) digest was 
done in PCR tubes at a constant temperature of 37°C for 12 hours. Reaction volumes were as 
follows: 5 µl of PCR product, 1 µl Thermo Scientific Tango Buffer, 0.25 µl MspI enzyme, 
and 3.75 µl of PCR grade water totalling a reaction volume of 10 µl. This allows for the 
genotyping of rs25531 through the use of capillary electrophoresis which was carried out at 
the Central Analytical Facility (CAF) at Stellenbosch University. Prior to capillary 
electrophoresis 5µl of product was used for electrophoresis on a 2.5% agarose gel to ensure 
that the digest was complete.  
The Mspl restriction enzyme has a 5’ CCGG 3’ recognition site, and rs25531 is an A>G SNP. 
This means that if a G allele is present, the restriction enzyme will cut the 5HTTLPR 
amplicon, however if an A allele is present, no RE digestion will occur. After digestion, a 
fragment of the amplicon remains FAM-labelled. This remaining fragment size, combined 
with the L and S fragment sizes, is used to determine the eventual combined genotype 
(Rs25531 alleles are indicated using lowercase a and g). The FAM-labelled fragment sizes (in 
bold) are as follows: 
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Sa/Sa  281 + 94 
La/La 325 + 94 
Sg/Sg  151 + 130 + 94 
Lg/Lg  151 + 174 + 94 
Lg/Sg  151 + 174 + 130 + 94 
Lg/Sa  151 + 281 + 174 + 94 
La/Sg  325 + 151 + 130 + 94 
 
Further genotyping was performed using the Sequenom’s iPLEX® Gold assay (Genome 
Quebec, Canada).  
The Sequenom’s iPLEX® Gold assay (henceforth referred to as Sequenom) allows for the 
genotyping of up to 40 markers. This method distinguishes alleles based on different masses 
of primer extension products. Target regions are amplified using a PCR reaction, after which 
unincorporated dNTPs are inactivated. This is followed by a primer extension reaction (the 
iPLEX reaction) which utilizes mass modified ddNTPs (Bradić et al., 2012). Nucleotides 
added differ according to the allele present directly downstream of the 3’ end of the primer. 
After a clean-up step the extended primers are transferred to a chip containing a specific 
matrix which allows for detection using matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry. The only limiting factor for the design of new assays for Sequenom 
genotyping is suitable primers in the region of interests (Bradić et al., 2012).  
KASP technology (LGC genomics, United Kingdom) was utilised to genotype those 
polymorphisms that could not be genotyped using the Sequenom technique. 
KASP genotyping assays are the proprietary genotyping technology of LGC Genomics (UK). 
A SNP-specific assay mix, as well as a universal KASP mastermix, is added to samples after 
which a thermal cycling reaction is performed. The KASP assay mix contains two allele-
specific forward primers and one common reverse primer, all of which are unlabelled.  The 
two allele-specific primers have unique tail sequences incorporated that correspond to a 
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universal fluorescence resonant energy transfer (FRET) cassette. During the thermal cycling 
step, the allele-specific primer binds to the template and elongates, incorporating the unique 
tail sequence to the newly formed strand. Subsequent rounds of cycling form complements of 
said tails sequence which allows the FRET cassette to bind to the DNA. The tail sequence 
stops the quenching effect on the FRET cassette which enables it to fluoresce.  
II.8. Statistical analyses 
Demographic and clinical characteristics were summarised using means and standard 
deviations, if approximately normally distributed, and as medians and ranges if non-normally 
distributed. Differences between groups (gender, ethnicity) were assessed using unadjusted 
linear models, transforming traits to normality where necessary. Subscales of the CTQ total 
were summarised by categorising the scores, and reporting number (%) within each category. 
Genotype counts (%) and HWE p-values were summarised separately for Xhosa and 
Coloured participants.  
General linear modelling was used to express CASI total score (AS) as a function of a 
genotype, additive allelic or haplotype variable, whilst adjusting for possible confounders. 
The possible confounders for association testing were age, gender, depression (CESD total 
score), resilience (CD-RISC total score), coping mechanisms (A-COPE total score), trait 
anxiety (STAIT total score), alcohol use disorders (AUDIT total score) and Childhood 
Trauma (CTQ total score). Genotypes were coded as three categories (2 degrees of freedom 
test), where alleles were coded as the number of minor alleles present (0,1 or 2). Haplotypes 
were also coded as the number present, and were inferred using the solid spine of linkage 
disequilibrium (LD) method using Haploview software (version 4.2) (Barrett et al., 2005). 
The only model used was additive allelic, however, controlling for the same confounding 
factors as for the single-locus analyses. 
Modelling was done separately for Coloured and Xhosa participants. Where significance was 
detected (p<0.05) dominant and recessive minor allele models of possible inheritance models 
were investigated, and gender effects were analysed. A best fit approach was used to 
determine which of the four possible models was used to estimate effects reported. All 
analyses were done using R (Team, 2012), and functions from R packages genetics (Warnes 
et al., 2011), haplo.stats (Sinnwell & Schaid, 2012) and effects (Fox, 2003).  


























III.1 Clinical and demographic data 
Of the 1149 original samples taken, 985 individuals were successfully genotyped and were 
stratified into ethnic groups, which were identified by means of self-report. Individuals self-
identified as White, Asian and other were excluded from further analysis due to the fact that 
there was only a total of 34 individuals in these categories. This resulted in a cohort size of 
951 of which 317 self-identified as Coloured (32.3%) and 634 self-identified as Xhosa 
(64.3%) (Table 3.1). 
Table 3.1. Ethnic distribution of participants 
 
  
 Count Percent 
White 21 2.1 
Coloured 317 32.2 
Xhosa 634 64.4 
Asian 1 0.1 
Other 12 1.2 
Total 985 100.0 
 
Table 3.2. Demographic and clinical data of the Xhosa and Coloured participants.  
Clinical/demographic characteristic Xhosa Coloured 
Female Male All Female Male All 
Number 375 (59%) 259 (41%) 634 188 (59%) 129 (41%) 317 
Age (years), mean (SD) 16.4 (2.1) 16.4 (2.0) 16.4 (2.1) 15.8 (1.7) 15.80 (1.5) 15.8 (1.6) 
CASI total, mean (SD)* 36.9 (6.2) 34.9 (6.2) 36.1 (6.3) 35.8 (6.6) 31.53 (6.3) 34.1 (6.8) 
STAIT, mean (SD)* 47.3 (8.3) 45.9 (6.6) 46.7 (7.6) 46.8 (9.4)  42.05 (8.7)  44.8 (9.4) 
CES-DC, mean (SD) 23.9 (11.1) 21.8 (10.3) 23.0 (10.8) 27.0 (12.4)  20.03 (11.9)  24.1 (12.6) 
CD-RISC, mean (SD)* 57.3 (18.9) 57.0 (19.7) 57.2 (19.2) 64.7 (17.6) 62.87 (18.8) 64.0 (18.1) 
A-COPE, mean (SD) 166.5 (20.3) 166.6 (23.1) 166.6 (21.5) 168.27 (22.3) 166.07 (22.4) 167.4 (22.4) 
CTQ Total, median (range)* 43 (2590) 44 (2594) 43 (2594) 40 (2596) 39 (2585)  40 (2596) 
AUDIT Total, median (range)* 0 (029) 0 (028) 0 (029) 1 (032) 2 (027)  2 (032) 
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Abbreviations: CASI, Childhood Anxiety Sensitivity Index; CTQ, Childhood Trauma Questionnaire; STAIT, 
State-Trait Anxiety Inventory; CES-DC, Center for Epidemiological Studies Depression Scale for children; 
AUDIT, Alcohol Use Disorders Identification Test; CD-RISC, Connor-Davidson Resilience Scale; A-COPE, 
Adolescent Coping Orientation for Problem Experiences 
There was no significant difference in age between male and female participants 
for either ethnic group (Xhosa p=0.911 and Coloured p=0.843 respectively). 
Significant differences between the two ethnic groups with regards to CASI total 
(p=0. 000005), STAIT total (p=0. 0007), and CD-RISC total (p=0. 0000002) were 
found. Further non-parametric analysis determined that there was a significant 
difference between the AUDIT (p=0.002) and CTQ total (p=0.008) scores (Table 
3.2). Table 3.3 list the CTQ scores of the participants for each subscale 
Table 3.3. Mean and standard deviation of CTQ subscale scores for Xhosa and Coloured participants. 
 Xhosa Coloured 

















































































The childhood trauma questionnaire has five subscales that determine the CTQ total. Each subscale focuses on a 
different form of trauma that may be experienced by an adolescent or child. Abbreviation: Standard Deviation 
(SD) 
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III.2 Genotype data 
Genotype data was generated for 19 variants in four different genes. Eighteen variants are 
SNPs and one, the 5HTTLPR, is a VNTR polymorphism. Table 3.4 shows the genotype 
counts for all variants genotyped. With the exception of 5HTTLPR, all the variants were > 90 
% successfully genotyped. Genotyping was conducted blind to diagnosis. All the genotyping 
data was in Hardy-Weinberg equilibrium for both ethnic groups, with the p-value for 
rejection set at p=0.003 (Table3.4).  
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Table 3.4 Genotype counts for all variants genotyped.  
Variant Homozygous allele count % Heterozygous allele count % Homozygous allele count3 % Total % of total genotyped 
rs3800373(FKBP5) AA = 370 39 AC = 447 47 CC = 135 14 952 97 
rs9296158(FKBP5) AA = 188 20 AG = 452 46 GG = 288 31 928 94 
rs737054(FKBP5) CC = 805 85 CT = 130 14 TT = 14 1 949 96 
rs1360780(FKBP5) AA = 109 12 AG = 432 46 GG = 406 43 947 96 
rs6926133(FKBP5) GG = 704 75 TG = 255 27 TT = 15 2 944 96 
rs9394309(FKBP5) AA = 663 71 AG = 244 26 GG = 22 2 929 94 
rs9470080(FKBP5) CC = 314 33 CT = 467 49 TT = 175 18 956 97 
rs11030099(BDNF) AA = 14 1 CA = 146 15 CC = 793 83 953 97 
rs6265(BDNF) CC = 874 91 CT = 77 8 TT = 8 1 959 97 
rs2049046(BDNF) AA = 101 11 AT = 419 45 TT = 402 44 922 94 
rs3813034(SLC6A4) AA = 566 62 AC = 298 33 CC = 42 5 906 92 
rs1042173(SLC6A4) AA = 587 61 AC = 319 33 CC = 49 5 955 97 
rs6354(SLC6A4) AA = 399 42 AC = 420 44 CC = 126 13 945 96 
rs25531(SLC6A4) AA = 676 76 AG = 200 22 GG = 18 2 894 91 
rs7209436(CRHR1) AA = 83 9 AG = 366 39 GG = 479 52 928 94 
rs4792887(CRHR1) CC = 374 39 CT = 427 45 TT = 156 16 957 97 
rs110402(CRHR1) AA = 85 9 AG = 374 40 GG = 478  51 937 95 
rs242924(CRHR1) GG = 511 54 TG = 358 38 TT = 85 9 954 97 
5HTTLPR LL = 435 48 LS = 398  44  SS = 74 8 907 92 
 
Totals include the genotype count for all ethnic groups. % of total genotyped expresses the total count of each variant as a percentage of the total number of participants. This 




Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
42 
 




Variant Alleles Xhosa  Coloured  Variant Alleles Xhosa  Coloured  

















AA 35 0.499 47 0.490 
CA 153   137   AG 211   149   
CC 13   24   GG 370   100   










CC 181 0.739 181 0.983 
AC 168   143   CT 310   108   
CC 18   26   TT 140   16   









AA 36 0.487 48 0.492 
CA 296   118   AG 214   149   
CC 104   22   GG 371   98   










GG 398 0.714 105 0.792 
A/G 140   58   TG 202   146   
G/G 13   5   TT 28   54   





L/L 293 0.011 126 0.533       
L/S 260   126        
S/S 33   37        
Total 586   289        
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Table 3.5 continued 
Variant Alleles Xhosa  Coloured  Variant Alleles Xhosa  Coloured  










AA 225 0.126 134 0.036 
CA 55   85   AC 315   124   
CC 574   205   CC 85   48   










AA 135 0.913 52 0.419 
CT 2   68   AG 311   132   
TT 0   7   GG 176   102   










CC 565 0.080 225 0.154 
AT  284     126     CT 59   67   
TT  259     135     TT 4   9   
Total  617     287     Total 628   301   





AA 70 0.160 38 0.164 
      AG 302   122   
      GG 254   140   
      Total 626   300   





AA 460 0.153 189 0.504 
            AG 152   88   
            GG 7   13   
            Total 619   290   





CC 189 0.561 115 0.435 
            CT 317   141   
            TT 121   52   
            Total 627   308   
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III.2.1 Association data 
Of the 18 variants genotyped only nine showed significant associations with CASI total 
scores (Anxiety sensitivity). Association was first tested across both genders and no 
statistically significant association observed between genotype and AS in the Xhosa sample, 
however significance was found in three variants in the Coloured sample. Rs737054 
(FKBP5) had significance in both the Additive allelic (p=0.04) and Dominant models 
(p=0.035) in the Coloured population. Rs737054 (FKBP5) showed a 1.47 (CI 95%: 0.1-2.84) 
increase in CASI score assuming a dominant model of inheritance. Rs23351 (SLC6A4) was 
found to be significant with recessive inheritance (p=0.04), however no significance was 
observed upon further stratification by gender. Furthermore, significant association was 
observed between 5-HTTLPR (SLC6A4) and AS in the Coloured population (p=0.046) within 
an additive allelic model of inheritance. Coloured participants show an increase of CASI 
score of 0.9 for every S allele present (CI 95%: 0.02-1.78). Association was tested further 
with the Xhosa and Coloured groups stratified by gender. Significance that was observed 
between 5-HTTLPR (SLC6A4) and CASI total scores with a recessive inheritance in Coloured 
males (p=0.016). Coloured males with the SS genotype had an estimated 3.73 (CI 95%:0.72-
6.74) higher mean CASI total score than those Coloured males with LL and LS genotypes.  
Rs3800373 (FKBP5) showed significant association with CASI total scores in the Coloured 
male sample only (p=0.034). Individuals with the heterozygous AC genotype had lower 
CASI total scores, by an average of 1.96 units (CI 95%: -3.75 to -0.17), than those with the 
CC genotype.  Rs9296158 (FKBP5) showed association with CASI total score when 
assuming a dominant model of inheritance in the Coloured male sample (p=0.007). Coloured 
males with at least one A allele had an average CASI total score that was 2.66 units (CI 95%: 
-4.538 to -0.789) lower than those males who had the GG homozygous genotype. 
Furthermore, rs737054 (FKBP5) also showed association with CASI total score in the 
Coloured male group (p=0.013). This association was found when assuming a dominant 
model of inheritance, Coloured males possessing at least one T allele had mean CASI total 
scores that were 2.72 units (CI 95%: 0.66 to 4.78) higher than males with a homozygous CC 
genotype. In the Xhosa male sample rs6926133 (FKBP5) was associated with CASI total 
score when assuming a recessive model of inheritance (p=0.019). CASI total scores for 
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Xhosa males homozygous for the T allele were 7.53 units (CI 95%: -13.996 to -1.058) lower 
than the scores for Xhosa males with at least one C allele. 
Rs7209436 (CHCR1) showed significant association with CASI total scores in both the 
Xhosa and Coloured male samples. For Xhosa males in an additive allelic model it was 
observed that with the addition of an A allele the CASI total score was reduced by 1.49 units 
(CI 95%: -2.69 to -0.30) (p=0.018). There was a significant association of CASI total score in 
Coloured males (p=0.02) when a dominant model of inheritance was assumed. Coloured 
males with at least one A allele had CASI total scores that were, on average, 2.12 units higher 
than Coloured males that were homozygous for the G allele. Rs110402 (CHCR1) also 
showed significant association with CASI total scores in both the Xhosa and Coloured male 
groups. In the Xhosa male group, a significant association was observed in an additive allelic 
model (p=0.023) where the addition of an A allele showed a reduction in CASI total score of 
1.47 units (CI 95%: -2.6 to -0.29). Within the Coloured male group there was a significant 
association assuming a dominant model of inheritance (p=0.045). As the association was not 
very significant the effect size was not determined. However, Coloured males who possessed 
at least one A-allele had higher average CASI total scores than those males homozygous for 
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Table 3.6 Association of CASI total score and genotype in Xhosa and Coloured population groups using additive allelic, dominant, and recessive models of inheritance 














Black Coloured Black Coloured Black Coloured Black Coloured 
rs3800373 
(FKBP5) 
C 0.5245 0.5502 0.6787 0.4413 0.3795 0.2965 0.6689 0.9206 
rs9296158 
(FKBP5) 
A 0.4821 0.1295 0.4334 0.1710 0.8856 0.0530 0.2377 0.8970 
rs737054 
(FKBP5) 
T 0.6929 0.1068 0.7859 0.0399 0.6494 0.0349 0.5499 0.4192 
rs6926133 
(FKBP5) 
T 0.7814 0.7870 0.8518 0.9279 0.7440 0.7704 0.5781 0.5968 
rs25531 
(SLC6A4) 
G 0.3277 0.1110 0.1531 0.5210 0.2137 0.9436 0.2649 0.0404 
5HTTLPR 
(SLC6A4) 
S 0.8304 0.1374 0.9921 0.0462 0.8125 0.0722 0.6264 0.1557 
rs7209436 
(CRHR1) 
A 0.8042 0.6888 0.5951 0.3899 0.7263 0.4327 0.5228 0.5585 
rs110402 
(CRHR1) 
A 0.8429 0.9252 0.6872 0.7446 0.8282 0.8691 0.5597 0.6952 
rs242924 
(CRHR1) 
T 0.4767 0.7209 0.6429 0.4425 0.4103 0.5967 0.5285 0.4497 
Significant p values are shown in boxes. All confounders for association testing were controlled for. Possible confounders were age, gender, depression (CESD total score), 
resilience (CD-RISC total score), coping mechanisms (A-COPE total score), trait anxiety (STAIT total score), alcohol use disorders (AUDIT total score) and Childhood 
Trauma (CTQ total score).  
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Table 3.7 Association of CASI total score with genotype in Xhosa and Coloured populations groups using additive allelic, dominant, and recessive models of inheritance 
stratified according to gender. 
    Genotype   Additive allelic 
Variants   Xhosa   Coloured   Xhosa Coloured 
 
Minor allele Female Male Female Male Female Male Female Male 
rs3800373 (FKBP5) C 0.9443 0.4319 0.8998 0.0984 0.9834 0.7027 0.7081 0.041 
rs9296158 (FKBP5) A 0.5032 0.9709 0.5852 0.0251 0.5408 0.811 0.9522 0.0112 
rs737054 (FKBP5) T 0.9527 0.3925 0.6217 0.0449 0.801 0.5399 0.3289 0.016 
rs6926133 (FKBP5) T 0.2597 0.046 0.7444 0.6936 0.6004 0.8287 0.6043 0.4634 
rs25531 (SLC6A4) G 0.2691 0.7731 0.5943 0.1835 0.1454 0.5255 0.8016 0.5453 
5HTTLPR (SLC6A4) S 0.5052 0.3908 0.4129 0.0475 0.3108 0.1964 0.3104 0.0362 
rs7209436 (CRHR1) A 0.3943 0.0617 0.8595 0.0602 0.2599 0.0184 0.5837 0.0252 
rs110402 (CRHR1) A 0.3982 0.0745 0.5996 0.1168 0.2234 0.023 0.3169 0.0463 
rs242924 (CRHR1) T 0.3972 0.1129 0.9817 0.3194 0.1767 0.3115 0.8713 0.13 
Significant p values are shown in boxes. MA (minor allele). All confounders for association testing were controlled for. Possible confounders were age, gender, depression 
(CESD total score), resilience (CD-RISC total score), coping mechanisms (A-COPE total score), trait anxiety (STAIT total score), alcohol use disorders (AUDIT total score) 
and Childhood Trauma (CTQ total score). 
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Table 3.7 Continued 
  Dominant Recessive 
Variants 
 
Xhosa Coloured Xhosa Coloured 
 
Minor allele Female Male Female Male Female Male Female Male 
rs3800373 (FKBP5) C 0.8856 0.3374 0.8318 0.0339 0.8008 0.5867 0.6462 0.2584 
rs9296158 (FKBP5) A 0.9791 0.8243 0.6346 0.0072 0.2753 0.8709 0.4898 0.1792 
rs737054 (FKBP5) T 0.8347 0.3559 0.3572 0.0125 0.7891 0.4998 0.5431 0.5503 
rs6926133 (FKBP5) T 0.8366 0.7206 0.5017 0.5513 0.1005 0.0193 0.884 0.4716 
rs25531 (SLC6A4) G 0.2081 0.6285 0.9896 0.9782 0.2183 0.5103 0.3156 0.0768 
5HTTLPR (SLC6A4) S 0.4758 0.1701 0.1937 0.1913 0.2779 0.7634 0.8568 0.0158 
rs7209436 (CRHR1) A 0.1825 0.0313 0.6542 0.02 0.8704 0.1372 0.6561 0.2317 
rs110402 (CRHR1) A 0.1758 0.0403 0.3451 0.0453 0.7322 0.1338 0.5251 0.2428 
rs242924 (CRHR1) T 0.1882 0.7019 0.9289 0.1956 0.4621 0.0368 0.8486 0.2401 
 
Significant p values are shown in boxes. MA (minor allele). All confounders for association testing were controlled for. Possible confounders were age, gender, depression 
(CESD total score), resilience (CD-RISC total score), coping mechanisms (A-COPE total score), trait anxiety (STAIT total score), alcohol use disorders (AUDIT total score) 
and Childhood Trauma (CTQ total score). 
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III.2.2 Interaction data 
Interaction between genotype and childhood trauma (CTQ total) was first tested for without 
stratification by gender. Subsequent investigations were performed in gender-stratified 
datasets. Rs3800373 (FKBP5) showed no interaction between genotype and CTQ total score 
before gender stratification in the Xhosa and Coloured samples. Nominal interaction between 
genotype and CTQ total score was seen in the male Coloured population using an additive 
allelic model of in heritance (p=0.049). In Coloured males for each addition of a C-allele 
there was a decrease in CASI total of 0.12 units for every unit increase in CTQ total score (CI 
95%: -0.24 to 0.00). Rs2049046 (BDNF) was found to have significant interaction with CTQ 
total score in Xhosa females under an additive allelic model (p=0.001). Xhosa females’ CASI 
total decreased by -0.14 units for every unit increase in CTQ total score with the addition of a 
C-allele (CI 95%: -0.22 to -0.06). Rs1042173 (SLC6A4) showed interaction with CTQ total 
score in the Xhosa sample as a whole (p=0.042). Assuming a recessive model of inheritance 
there was a 0.315 unit decrease in CASI total for every unit increase in CTQ total score in 
those Xhosa participants homozygous for the C-allele compared to those with at least one A-
allele (CI 95%: -0.611 to -0.019). Rs6354 (SLC6A4) also showed no interaction before 
gender stratification, however was seen to be significant in Xhosa males when considering an 
additive allelic model of inheritance (p=0.016). In the Xhosa male sample, there was a 0.12 
unit decrease in CASI total score for every unit increase in CTQ total score (CI 95%: -0.21 to 
-0.02) for each C-allele present. Exact p values can be found in Table 3.8 and Table 3.9; 
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Variant MA Xhosa Coloured Xhosa Coloured Xhosa Coloured Xhosa Coloured 
rs3800373 
(FKBP5) 
C 0.8175 0.9694 0.9647 0.7558 0.6671 0.8110 0.8155 0.8515 
rs2049046  
(BDNF) 
A 0.1150 0.0934 0.1169 0.6211 0.0443 0.6066 0.9958 0.0733 
rs1042173 
(SLC6A4) 
C 0.0581 0.8805 0.0424 0.6266 0.1099 0.7137 0.2513 0.8762 
rs6354  
(SLC6A4) 
C 0.2259 0.9120 0.4100 0.7973 0.9632 0.9348 0.2937 0.5001 
Significant p values are shown in boxes. MA (minor allele). All confounders for association testing were controlled for. Possible confounders were age, gender, depression 
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Additive 










Variant MA female male female male female male female male 
rs3800373 
(FKBP5) 
C 0.3698 0.1956 0.8488 0.4074 0.4006 0.2773 0.6770 0.0486 
rs2049046  
(BDNF) 
A 0.0058 0.0570 0.4556 0.3721 0.0010 0.0934 0.2043 0.3142 
rs1042173 
(SLC6A4) 
C 0.6293 0.8963 0.9147 0.4909 0.4923 0.2734 0.5449 0.3539 
rs6354  
(SLC6A4) 




   
Recessive 










Variant MA female male Female male female male female male 
rs3800373 (FKBP5) C 0.7684 0.3707 0.7351 0.1041 0.1561 0.1047 0.6967 0.2104 
rs2049046  
(BDNF) 
A 0.0015 0.4373 0.6188 0.1824 0.0863 0.0181 0.2219 0.8604 
rs1042173 
(SLC6A4) 
C 0.5442 0.4094 0.9762 0.2632 0.4591 0.7471 0.6464 0.6258 
rs6354  
(SLC6A4) 
C 0.1043 0.0721 0.9430 0.7106 0.7066 0.0176 0.8578 0.9102 
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Significant p values are shown in boxes. MA (minor allele). All confounders for association testing were controlled for. Possible confounders were age, gender, depression 
(CESD total score), resilience (CD-RISC total score), coping mechanisms (A-COPE total score), trait anxiety (STAIT total score), and alcohol use disorders (AUDIT total 
score). 
 
Table 3.10 Variant Interaction with CTQ showing effect sizes and confidence intervals. 
Variant Sample Group Inheritance Comparison 
 






Additive allelic Added C-allele -0.12 0.049 -0.24 0 
rs2049046 
(BDNF) 
Xhosa females Additive allelic Added A-allele -0.14 0.001 -0.22 -0.06 
rs1042173 
(SLC6A4) 
Xhosa all Recessive CC AA+AC -0.315 0.037 -0.611 -0.019 
rs6354 
(SLC6A4) 
Xhosa males Additive allelic Added C-allele -0.12 0.016 -0.21 -0.02 
All confounders for association testing were controlled for. Possible confounders were age, gender, depression (CESD total score), resilience (CD-RISC total score), coping 
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III.3 Haplotype analysis 
Haplotype analysis was performed using the Linkage disequilibrium (LD) package in 
RStudio for all the genotyped variables and were confirmed using Haploview for those 
variables that were SNPs. In Haploview LD plots with D’ values according to Gabriel et 
al.,2002 recommended CI criteria (default Haploview settings) were created (Figure3.1 and 
Figure 3.2). 
 
Figure 3.1 Linkage disequilibrium map for the Xhosa participants, D’ values are depicted in the diamonds, with 
darker red depicting stronger LD. The LD map was created using the confidence intervals (CI), implemented in 
Haploview (Gabriel et al. 2002). 
 
 




Figure 3.2 Linkage disequilibrium map for the Coloured participants, D’ values are depicted in the diamonds, 
with darker red depicting stronger LD. The LD map was created using the confidence intervals (CI), 
implemented in Haploview (Gabriel et al. 2002). 
Table 3.11 Haploblocks observed in Xhosa and Coloured sample groups as determined using confidence 
intervals. 
Haploblock Gene Ethnicity 
rs25531 and 5HTTLPR SLC6A4 Xhosa 
rs3813034 and rs1042173 SLC6A4 Coloured 
rs7209436, rs4792887 and rs110402 CRHR1 
Xhosa and 
Coloured 





Association with anxiety and interaction of CTQ and anxiety of the different haploblocks was 
tested for within Xhosa and Coloured samples. There was only one significant association 
with anxiety in the Xhosa sample when both genders were considered together (Table3.12). 
Significance was observed between the rs25531 and 5HTTLPR haplotype and AS in the 
Xhosa sample (p=0.021). Xhosa participants who carried the G-L haplotype showed an 
estimated decrease in CASI total score of 1.29 for each copy of the G-L haplotype compared 
to the reference A-L haplotype (p=0.010) (Table 3.13). 
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Table 3.12 Association of Haploblocks with anxiety and Interaction between Haploblocks and CTQ with Anxiety for Xhosa and Coloured participants without gender 
stratification.  
 Haploblock Both genders 
  Association Interaction 
 
Xhosa Coloured Xhosa Coloured 




rs3813034 and rs1042173 (SLC6A4)   0.414 
 
0.733 
rs7209436, rs4792887 and rs110402 (CRHR1) 0.771 0.354 0.115 0.478 
rs3800373, rs9296158, rs737054, rs6926133, rs1360780, and rs9394309 
(FKBP5) 
0.347 0.638 0.353 0.592 
 
Table 3.13 rs25531 and5HTTLPR haplotype association with AS in the Xhosa sample. Effect is estimated in the difference between specific haplotype and reference 
haplotype. Significance was taken at p < 0.05. 
 
 
rs25531 and 5HTTLPR Haplotype association with AS   
      95% CI   
rs25531 5HTTLPR hap.freq Effect Lower Upper p-value 
A S 0.29 -0.308 -1.05 0.44 0.419 
G L 0.12 -1.293 -2.28 -0.31 0.01 
G S 0.01 2.228 -1.4 5.85 0.229 
A L 0.58 Reference haplotype 
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No further association was found when the Xhosa sample was stratified by gender for the rs25531 and 5HTTLPR haplotype (males: p=0.177) 
and females: p=0.071) (Table 3.14). 
 
Table 3.14 Association of Haploblocks with anxiety for Xhosa and Coloured participants with gender stratification. All confounders for association testing were controlled 
for. Possible confounders were age, gender, depression (CESD total score), resilience (CD-RISC total score), coping mechanisms (A-COPE total score), trait anxiety (STAIT 
total score), alcohol use disorders (AUDIT total score) and Childhood Trauma (CTQ total score). 
 Haploblock Association with AS 
  Xhosa Coloured 
 
Female Male Female Male 
rs25531 and 5HTTLPR (SLC6A4) 0.070 0.177     
rs3813034 and rs1042173 (SLC6A4)   
 
0.553 0.982 
rs7209436, rs4792887 and rs110402 (CRHR1) 0.192 0.341 0.905 0.026 
rs3800373, rs9296158, rs737054, rs6926133, rs1360780, and rs9394309 
(FKBP5) 
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When participants were stratified by gender there was an association between the rs7209436, rs4792887 and rs110402 (CRHR1) haplotype and 
AS in Coloured males only (p=0.026). Coloured males carrying the A-C-A haplotype showed an estimated average increase of CASI total score 
of 2.29 units for each additional copy of the A-C-A haplotype compared to the reference G-T-G haplotype (p=0.004). 
No interaction between haplotype and CTQ total score and AS was observed when the Xhosa and Coloured sample groups were analysed in total 
(without gender stratification)(Table 3.12). However, significant interaction was observed in the Xhosa female participants and the rs25531 and 
5HTTLPR (SLC6A4) haplotype (p=0.014). Xhosa females who possessed the G-L haplotype showed a 0.13 unit reduction in CASI total score for 
every unit increase in CTQ total score (p=0.003) compared to those females with the A-L haplotype (Table 3.16). 
Table 3.15 Interaction between haplotype and CTQ total score with AS in Xhosa and Coloured participants, stratified by gender. 
Haploblock Interaction with CTQ on anxiety 
 
Xhosa Coloured 
  Female Male Female Male 
rs25531 and 5HTTLPR (SLC6A4) 0.014 0.904 
 
  
rs3813034 and rs1042173 (SLC6A4)     0.234 0.603 
rs7209436, rs4792887 and rs110402 (CRHR1) 0.472 0.422 0.521 0.857 
rs3800373, rs9296158, rs737054, rs6926133, rs1360780, and rs9394309 
(FKBP5) 
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Table 3.16 rs25531 and5HTTLPR haplotype interaction with CTQ total score on AS in the Xhosa female 
sample. Effect is estimated in the difference between specific haplotype and reference haplotype. Significance 
was taken at p < 0.05. 
rs25531 and 5HTTLPR Haplotype interaction with 
CTQ total score on AS 
 
rs25531 5HTTLPR hap.freq Effect se p-value 
A S 0.28 -0.07 0.04 0.071 
G L 0.13 -0.13 0.05 0.003 
G S 0.01 -0.16 0.12 0.204 
A L 0.58 Reference haplotype 
 
No significant association was observed between the FKBP5 haploblock (rs3800373, 
rs9296158, rs737054, rs6926133, rs1360780, and rs9394309 (FKBP5)) and AS, however 
there was an interaction with CTQ on anxiety in the Coloured male sample (p=0.034) (Table 
3.15). CASI total scores (representing AS) were found to increase, on average, by 0.43 units 
for every one unit increase in CTQ total score (representing level of childhood trauma) in 
Coloured males with the haplotype A-G-C-T-A-A, relative to Coloured males with the A-G-C-
G-G-A haplotype (p=0.007) (Table 3.17). Coloured males who carried the C-A-C-T-A-G 
haplotype showed an estimated average decrease in CASI total scores of 0.22 (p=0.012) 
(Table 3.17), compared to the reference A-G-C-G-G-A haplotype. Rare haplotypes were 
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Table 3.17 rs3800373, rs9296158, rs737054, rs6926133, rs1360780, and rs9394309 (FKBP5) haplotype interaction with CTQ total score on AS in the coloured male sample. 
Haplotypes were tested individually after which rare haplotypes were combined (haplotype frequency < 0.01).  
FKBP5 haplotype interaction with CTQ on AS 
 
rs3800373 rs9296158 rs737054 rs6926133 rs1360780 rs9394309 hap.freq coef se pval 
haplotype 1 A A C G G A 0.04  0.01 0.13 0.906 
haplotype 6 A G C T A A 0.01  0.43 0.16 0.007 
haplotype 7 A G T G G A 0.06 -0.19 0.1 0.069 
haplotype 8 C A C G A A 0.18 -0.05 0.08 0.516 
haplotype 9 C A C G A G 0.04  0.01 0.2 0.958 
haplotype 10 C A C G G A 0.04 -0.05 0.11 0.668 
haplotype 12 C A C T A G 0.14 -0.22 0.08 0.012 
rare 
haplotype 
* * * * * * 0.01 -0.58 0.51 0.257 
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The present study examined genetic and clinical data, consisting of anxiety sensitivity and 
childhood trauma, obtained from Xhosa and Coloured South African adolescents to 
determine whether AS can be utilized as a predictive tool to determine early risk 
susceptibility for anxiety disorder diagnoses.  
IV.1 Variants with in FKBP5, SLC6A4, CRHR1 and BDNF may serve as potential early 
detection biomarkers for susceptibility risk for anxiety disorders  
IV.1.1 FKBP5 
Association between AS and four SNPs in FKBP5 were found to be significant in the 
Coloured sample. Firstly, there was a significant association between AS and rs737054 in the 
Coloured group as a whole (Table 3.7). This significance persisted in Coloured males 
(p=0.016), but was not seen in females (p=0.329). Why rs737054 is significant in Coloured 
males only is unclear. However, cortisol level differences between males and females in the 
context of anxiety have been described in literature before (Kudielka et al., 2004; 
Schiefelbein and Susman, 2006). Although the precise functional implications of rs737054 
are not known, this variant could play a role in the regulation of cortisol secretion, as FKBP5  
has been linked to cortisol level changes in response to stressors (Buchmann AF et al., 2014; 
Mahon et al., 2013a). More specifically FKBP5 has been found to play a role in emotion 
processing via amygdala activity (Holz et al., 2015), which could allude to a possible 
mechanism by which variation in FKBP5 could confer susceptibility to anxiety and related 
disorders. Despite a lack of knowledge concerning the functional role of rs737054, it is 
important to note that this variant is located within a highly conserved region of intron 5 
which has been previously reported to  have regulatory potential (King et al., 2005; Willour 
et al., 2009). Further studies are required to fully characterize the extent to which the variant 
may influence AS as well as anxiety and anxiety-related disorders. 
When stratifying for gender, the rs3800373 and rs9296158 were both found to be 
significantly associated with AS under a dominant model of inheritance (Table 3.7). 
rs3800373 showed an average decrease in AS in Coloured males who were heterozygous 
(AC) compared to Coloured males who were homozygous for the C allele. This variant has 
been studied extensively with regard to cortisol levels in response to stress (Comasco et al., 
2015; Ising et al., 2008; Mahon et al., 2013a) as well as its interaction with childhood trauma 
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(Binder et al., 2008; Buchmann AF et al., 2014; Luijk et al., 2010). The CC genotype has 
been associated with higher levels of cortisol in response to stress and dysregulation of the 
HPA axis (Binder et al., 2004b; Collip et al., 2013; Ising et al., 2008; Luijk et al., 2010). Our 
findings support where a heterozygous advantage was observed.   AC individuals showed a 
higher relative fitness compared to CC homozygotes, which is in line with previous findings. 
Furthermore, the GxE effect observed in our study (Table 3.9) is congruent with previous 
studies where the modulatory effect of childhood trauma was limited to males only, and is 
seen to be desensitizing (Comasco et al., 2015). 
In this study the rs9296158 was found to be associated with low AS scores in individuals 
possessing at least one A allele.  Unlike rs3800373, this finding contradicts previously 
reported literature(Collip et al., 2013; White et al., 2012; Zimmermann P et al., 2011), where 
the A allele was found to confer increased risk for post-traumatic stress disorder 
(PTSD)(Binder et al., 2008). It may be that this variant, while predisposing individuals to risk 
for the development of PSTD, may infer protection in the South African cohort. Considering 
interaction, in haplotype analyses CTQ modified the relationship between AS and variants 
within FKBP5.  Haplotype 12 (coef = -0.22; Table3.16) was found to be significant in the 
Coloured male sample (p=0.012) and reduced AS scores as the severity of childhood trauma 
increased. This haplotype was not the most significant finding in this analysis, however both 
minor alleles (C allele, rs3800373 and A allele, rs9296158) were present in that haplotype. 
This could mean that the desensitizing effect discussed for rs3008373 and rs9296158 above 
are collectively responsible for the reduced susceptibility to AS observed. This theory is 
strengthened by the opposing directional effect observed when both major alleles are present, 
respectively (haplotype 6, coef = 0.43; Table 3.17). 
As shown above, the significant associations observed for variants within FKBP5 have 
previously been reported to be associated with a risk for developing anxiety- or anxiety-
related disorders. The association of these same variants with AS independent of an anxiety 
disorder diagnosis flags these variants as potential early predictive biomarkers that may be 
used in a clinical setting for the early assessment of risk to develop anxiety disorders.  That 
said, it is important to note that significant findings were isolated to a single ethnic group and 
gender. Validation of the findings presented here in a replication cohort, as well and 
characterization in other ethnic groups, is warranted.  




The 5HTTLPR is a region in SLC6A4 that has been extensively studied in relation to 
psychiatric disorders such as depression (Ho et al., 2013; Kendler et al., 2005; Power et al., 
2010b; Sharpley et al., 2014; Van der Auwera et al., 2014), panic disorder, bipolar disorder, 
affective disorders, and other psychiatric symptoms (Gyawali et al., 2010; Jorm et al., 1998b; 
Laucht et al., 2009a; Tharoor et al., 2013). It has also been studied in relation to anxiety 
disorders and AS (Klauke et al., 2011c; Laucht et al., 2009a; Stein et al., 2007b). In this 
study, the S allele was found to be associated with increased AS scores in the Coloured 
population (p=0.046) (Table3.5).  This is in line with literature which has reported the S allele 
as a risk allele for the development of depression (Haenisch et al., 2013), as well as linked to 
higher levels of AS (Zavos et al., 2012b). This increase in AS was even more pronounced in 
Coloured males homozygous for the S allele compared to those who were heterozygous, or 
homozygous for the L allele (effect size = 3.37) (section 3.2.1).  This, again, supports what is 
seen in literature (Haenisch et al., 2013). Neuroimaging studies have found that carriers of the 
S allele show increased amygdala activation compared to LL genotype carriers, which has 
been suggested as a possible mechanism for susceptibility risk to anxiety disorders (El-Hage 
et al., 2013). 
Rs25531 is a SNP that is included in most studies looking at 5HTTLPR as it has been 
reported to modify the expression of the LL genotype in that the presence of a G allele (Lg) 
has been associated with decreased serotonin reuptake, allowing for a phenotype similar to 
that of the S allele (Hariri and Holmes, 2006; Oathes et al., 2015; Parsey et al., 2006). 
Haplotype analysis of rs25531 and 5HTTLPR yielded a decrease in AS in the Xhosa sample 
(Table 3.13). When stratifying for gender, childhood trauma was found to modify AS scores 
in Xhosa females for the same haplotype, presented as a 0.13 AS total score unit decrease in 
AS for every unit increase in childhood trauma (Table 3.16). These effects are in contrast 
with the above mentioned literature where the expected effect of the Lg allele, which is 
associated with increased levels of anxiety sensitivity, especially in the presence of adverse 
life events (Oathes et al., 2015; Stein et al., 2007b) is not seen in our study. 
The relationship between two additional variants and AS were found to be modified by with 
increasing severity of childhood trauma. The first, rs1042173 in the Xhosa sample as a whole 
(Table 3.8) and the second, rs6354 in Xhosa males only. Rs1042173 is often studied in the 
Stellenbosch University  https://scholar.sun.ac.za
64 
 
context of substance dependence and addiction (Demers et al., 2014; Johnson et al., 2011; 
Kenna GA et al., 2012; Seneviratne et al., 2013, 2009) as well as in suicidality studies (El-
Sayed et al., 2012; Enoch et al., 2013; Pinto et al., 2011). There are few studies that have 
definitively linked this variant to changes in anxiety, however rs1042173 is found in the 3’ 
untranslated region (3’-UTR), which could account for a translational modification leading to 
decrease in anxiety sensitivity in the presence of trauma. Rs1042173 has been found to 
disrupt certain miRNA binding, more specifically miRNA 135 (“miRdSNP,” n.d.), which has 
been linked to alterations in anxiety and depression within mouse models (Issler et al., 2014). 
Furthermore levels of miRNA 135 were found to be significantly lower in patients with 
depression and miRNA have been linked in literature to adaptive responses to stress and 
anxiety (Haramati et al., 2011; Issler et al., 2014). Since rs1042173 possibly disrupts miRNA 
binding we would expect to see an increase in AS as the proposed function of miRNA 135 
would be as an endogenous antidepressant/anxiolytic (Issler et al., 2014). In our cohort the 
interaction with CTQ shows a decrease in AS, which lend credence to desensitizing effect of 
childhood trauma 
In Xhosa males rs6354 was associated with decreased AS scores as the severity of childhood 
trauma increased (Table 3.9). This variant is found in the 5’ untranslated region (5’-UTR), 
postulating the modified relationship to AS may be due to potential regulatory mechanisms. 
There are no published studies indicating that this finding is limited to males only.  
Inconsistency in  findings across studies  has been linked to variation in age of participants 
included in those studies (Uddin et al., 2010).  
Rs6354 has been linked to depression and anxiety in other studies (Ho et al., 2013; Liu et al., 
2010; Su et al., 2009; Wray et al., 2009)  with the A allele in particular having been found to 
be associated with increased risk for anxiety and depression (Wray et al., 2009).  It is 
therefore plausible that the variants found to be significant in this study, and previously 
reported to be associated with risk of developing anxiety disorders, may be potential 
biomarkers when used in conjunction with AS clinical assessments to identify individuals at 
risk for developing anxiety disorders. 
 
 




There is evidence for the involvement of CRHR1 in mood and anxiety disorders (Holsboer 
and Ising, 2010; Klengel et al., 2013b; Spijker and Van Rossum, 2012). Previous studies have 
shown that a haplotype (rs7209436-rs110402-rs242924; A-A-T) increased the risk for stress-
related disorders, such as PTSD and depression (Bradley RG et al., 2008; White et al., 2013). 
In this study, rs7209436 A-allele was associated with increased AS in Coloured males.  The 
directional effect, however, was reversed in Xhosa males (Section 3.2.1; Table 3.7). 
Furthermore, rs110402 presented significant associations in both Xhosa and Coloured male 
sample groups.  
Haplotype analyses identified a single significant haplotype block (rs7209436-rs4792887-
rs110402; A-C-A) in our Coloured, male cohort (Table 3.14). Coloured males who had the A-
C-A haplotype were found to have a higher AS. This finding is concordant with the 
aforementioned literature.  Furthermore, these findings support observations of gender 
specific effects for variation in genes involved in steroid hormones (as seen with FKBP5 
above (Mahon et al., 2013b)). Sex differences in stress responses has been shown in literature 
as well as differences in amygdala and hippocampus function (Pagliaccio et al., 2015). This 
suggests that the male effects seen in our cohort may be linked to cortisol regulation and 
function in response to stress and traumatic life events. 
IV.2 Limitations 
IV.2.1 Cohort size and ethnic factors 
The sample size of this study may be considered reasonable; however, the loss of 
participants, whether it was from sampling error or wet bench error is a limitation. A 
confounding factor may be population stratification. Participants were asked to self-classify 
themselves, of which the largest ethnic groups were Xhosa followed by Coloured. The Xhosa 
ethnic group consisted of mainly isiXhosa speaking individuals which is the second largest 
ethnic group in South Africa (“South Africa’s population,” n.d.). Although there is no 
specific data related to the underlying genetic substructure in the Xhosa population, it has 
been found that there is relative genetic homogeneity within the population group (Bryc et al., 
2010; Niehaus et al., 2005; Tishkoff et al., 2009; Veeramah et al., 2012). In contrast to this, 
the South African Coloured population comprises Khoesan, Bantu-speaking, European and 
Stellenbosch University  https://scholar.sun.ac.za
66 
 
Asian ancestry (“South Africa’s population,” n.d.). This results in a high level of genetic 
heterogeneity which could account for some of the discrepancies found in this study.   
IV.2.2 Clinical data 
All of the screening tests employed to determine the clinical variables used in this study were 
gathered using retrospective and self-report methods and may be subject to some biases such 
as recall bias. Although some of the testing methods have built in methods to correct for 
certain biases it is always prudent to keep them in mind as possible explanations for 
discrepancies or outlier data. The South African population presents a unique problem when 
it comes to any study involving complex disorders with multifactorial aetiology. The 
population distribution makes any sort of generalization of findings untenable (Seedat et al., 
2008) not only from a psychopathological view, but also from a genetic perspective. For this 
reason, the findings reported in the previous section were necessarily distributed into Xhosa 
and Coloured population groups.  
 
IV.2.3 Childhood trauma questionnaire  
The CTQ consists of five subscales: physical neglect, emotional abuse, emotional neglect, 
physical abuse, and sexual abuse. Some of the subscales have been reported to be more 
associated with anxiety disorders. For the purposes of this study CTQ total scores were 
considered, however using each individual subscale may have yielded different associations 
and interactions.  
IV.2.4 Polymorphism selection 
A TagSNP approach was used to identify specific SNPs within the genes of interest. This 
approach is flawed in that the population data from www.hapmap.org does not necessarily 
correlate with the South African population. To account for this builds from different 
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IV.2.5 Statistical analysis 
The exploratory nature of the study placed some limitations on the rigour of the statistical 
analysis. No correction for multiple testing was applied to avoid the chance of excluding 
certain associations. 
IV.2.6 BDNF 
BDNF is well studied in relation to depression and anxiety, however in our cohort there were 
difficulties in performing statistical analysis on our data. This was due to the fact that there 
were low counts of certain genotypes in both the Xhosa and Coloured participants (Table3.4). 
 
IV.3 Future studies 
Findings in the FKBP5 gene in our study were limited to Coloured males only, similarly 
findings in CRHR1 were also limited to one sex. These findings may point to gender specific 
variations in genes regulating steroid hormone function, which could be an area that future 
studies could examine. Our findings also implicate HPA axis dysregulation and possible 
involvement of certain brain regions such as the amygdala in the aetiology of anxiety 
disorders. Further study into the functionality of certain SNPs such as rs737054 (FKBP5) and 
others may also bring new insights to the mechanisms underlying susceptibility risk to 
anxiety disorders manifesting in adolescence and adulthood.   
Future studies should use the CTQ subscales in conjunction with CTQ total scores. Some of 
the subscales such as emotional neglect and abuse have been found to be associated with 
greater symptom severity in social anxiety disorder (Simon et al., 2009). Using the subscales 










This study aimed to characterize genetic variation previously reported to be involved in 
anxiety- and anxiety—related disorders as potential early predictors in susceptibility for 
disease.  In this study we presented significant findings for variants within SLC6A4, BDNF, 
CRHR1, and FKBP5 and AS.  AS may be seen as a precursor to the development of anxiety- 
and anxiety-related disorders, and therefore a potential clinical marker facilitating early 
diagnoses.  The identification of significant associations between AS and variants previously 
associated with risk for an anxiety disorders highlights these as potential candidate molecular 
markers for facilitating early diagnosis in conjunction with the currently available clinical 
tools.  Furthermore, this study identified significant modifying effects of early adversity on 
anxiety-related phenotypes, in this case AS.  Overall our findings show that increased 
severity of childhood adversity served to desensitize individuals to the anticipation of 
anxiety-associated symptoms.  Whether this hypothesized desensitization serves as protective 
against the development of anxiety disorders, contributes to the pathogenicity of these 
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